| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441623 | European Journal of Cancer | 2016 | 10 Pages |
Abstract
In this study, US was at least as good as breast MRI in providing information on residual tumour size post-neoadjuvant chemotherapy. However, both modalities suffered from a substantial percentage of over- and underestimation of tumour size and in addition both showed a low negative predictive value of pathologic complete remission (Gov nr: NCT00314977).
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Birgit E.P.J. Vriens, Bart de Vries, Marc B.I. Lobbes, Saskia M. van Gastel, Franchette W.P.J. van den Berkmortel, Tineke J. Smilde, Laurence J.C. van Warmerdam, Maaike de Boer, Dick Johan van Spronsen, Marjolein L. Smidt, Petronella G.M. Peer,